{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:19:12Z","timestamp":1762100352218},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDTCHD"],"published-print":{"date-parts":[[2005,2,1]]},"DOI":"10.2174\/1568006053004985","type":"journal-article","created":{"date-parts":[[2005,3,18]],"date-time":"2005-03-18T04:24:15Z","timestamp":1111119855000},"page":"75-84","source":"Crossref","is-referenced-by-count":10,"title":["Azimilide, A Novel Oral Class III Antiarrhythmic for Both Supraventricular and Ventricular Arrhythmias"],"prefix":"10.2174","volume":"5","author":[{"given":"Robert","family":"VerNooy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mangrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Target -Cardiovascular & Hematological Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/90379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T10:00:33Z","timestamp":1448272833000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1568-0061&volume=5&issue=1&spage=75"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568006053004985","relation":{},"ISSN":["1568-0061"],"issn-type":[{"value":"1568-0061","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2,1]]}}}